Tumorzentrum der Universität Erlangen-Nürnberg

HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance () Branz A, Matek C, Lange F, Bahlinger V, Klümper N, Hölzel M, Strissel P, et al. Journal article Assessment of a fully-automated diagnostic AI software in prostate MRI: Clinical evaluation and histopathological correlation () Bayerl N, Adams LC, Cavallaro AJ, Bäuerle T, Schlicht M, Wullich B, Hartmann A, et al. Journal article Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer (2024) Seitz K, Goossens C, Hübner H, Gaß P, Uhrig S, Heindl F, Emons J, et al. Journal article The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany (2024) Krebs M, Haller F, Spörl S, Gerhard-Hartmann E, Utpatel K, Maurus K, Kunzmann V, et al. Journal article Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinoma (2024) Struckmeier AK, Buchbender M, Lutz R, Agaimy A, Kesting MR Journal article Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk. (2024) Büttner T, Zarbl R, Krausewitz P, Strieth S, Kristiansen G, Eckstein M, Ralser DJ, et al. Journal article, Original article Medication safety with oral antitumour therapeutics in paediatrics (youngAMBORA): A mixed-methods approach towards a tailored care program. (2024) Lensker P, Cuba L, Geßner K, Fromm M, Dörje F, Metzler M Journal article Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) in Penile Squamous Cell Carcinoma-No Evidence for a Role in Carcinogenesis. (2024) Fiegl A, Wendler O, Giedl J, Gaisa NT, Richter G, Campean V, Burger M, et al. Journal article AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer. (2024) Bannier PA, Saillard C, Mann P, Touzot M, Maussion C, Matek C, Klümper N, et al. Journal article A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. (2024) Cuba L, Dürr P, Geßner K, Häcker B, Fietkau R, Siebler J, Pavel ME, et al. Journal article